HOME >> BIOLOGY >> NEWS
UV Skin Damage In A Different Light

Despite all the warnings to avoid exposure to the sun and to wear sunscreen, scientists don't really know how the sun damages our skin. Now, they're a bit closer to the answer.

Two scientists recently discovered that sunlight triggers a harmful reaction when it strikes a molecule in our skin--ironically a molecule once thought to be "nature's sunscreen." The work suggests the science behind the sagging, leathery skin typical of long-term sun worshipers, and may also shed light on how ultraviolet light causes skin cancer.

"We studied a natural component of human skin exposed to ultraviolet light and uncovered a new chemical reaction that may contribute to aging [of the skin] and cancer," said Dr. John Simon, who led the study.

The research will appear in the September 1 issue of the Proceedings of the National Academy of Sciences. The work was conducted at the University of California, San Diego by Dr. John D. Simon (who is now at Duke University), and his graduate student Kerry Hanson (who is now a postdoctoral fellow at the University of Illinois at Urbana-Champaign).

The sun's harmful rays come in two flavors: ultraviolet A and ultraviolet B. Evidence mounts that ultraviolet A and B both play a role in causing skin cancer and photoaging, which is characterized by deep, premature wrinkles, thickened skin, and age spots.

Time, gravity, and heredity notwithstanding, "something like 90 percent of all the visible signs of aging are from ultra-violet sources," said Dr. Kerry Hanson. "Photoaging is not just a cosmetic effect. It destroys the integrity of your skin."

The focus of this study is the sun-sensitive molecule called trans-urocanic acid (t-UA). Formed in the top layer of the skin, t-UA molecules cover our bodies, acting like antennae for light. In the 1950s, urocanic acid was hailed as a "natural sunscreen" because it absorbs ultraviolet B light. It was thus thought to protect against damage by such rays, which can potentially
'"/>

Contact: Alisa Machalek
machalea@nigms.nih.gov
(301) 496-7301
NIH/National Institute of General Medical Sciences
1-Sep-1998


Page: 1 2 3

Related biology news :

1. Damaged genes in aging human brain provide clues to cognitive decline
2. Damage from acid rain pollution is far worse than previously believed
3. Damaged DNA synthesis enzyme shown to cause progressive muscle weakening
4. Damaged spinal cord found to have greater potential for nerve regrowth than thought possible
5. Concern Unfounded About Damage From Vitamin C
6. Enzyme Required To Prolong Life In Worms Identified By Researchers At Columbia; Key Enzyme Appears To Protect Animal Cells From Oxidative Damage
7. UCSF Scientists Report On A Transcription Factor That Could Stimulate Heart Cells To Repair Damage Caused By Heart Attacks Or Birth Defects
8. Jefferson Scientists Find Further Proof Of Damage To The FHIT Gene In Breast Cancers
9. Study Indicates Adolescent Smokers Are More Susceptible To Long-Term DNA Damage From Smoking Than Adults Smokers
10. Spider Venom Stops Stroke Brain Damage
11. Common Respiratory Virus Identified As One Cause Of Heart Muscle Damage That Can Lead To Sudden Death

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Skin Damage Different Light

(Date:8/25/2015)... LAKE CITY and BELLEVUE, Wash. ... global leader in advanced robotic systems, announced today it ... robotic unmanned ground vehicle (UGV), at the National Tactical ... City.  The Guardian S is the ... the culmination of years of research and in-field trials ...
(Date:8/20/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market and creator of the ... Card Alliance and the EMV Migration Forum.  ... Card Alliance Latin America (SCALA) Chapter provides NXT-ID, Inc. ... leaders promoting adoption of smart card technology. ...
(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions ... the entire spectrum of clinical research, is proud to ... the company,s comprehensive SaaS-based eClinical technology platform, has led ... the first two quarters of 2015.   Q2 2015 ... largest quarters measured by contract value sold in the ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4MedNet Solutions Experiences Explosive Corporate Growth 2
(Date:9/2/2015)... , Sep. 02, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... to their offering. This report follows ... characteristic that can be objectively measured and evaluated ... processes as well as pharmacological responses to a ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, Inc., ... in the multicenter Phase 2 clinical trial of ... treatment of recurrent subfoveal choroidal neovascularization secondary to ... a unique vascular endothelial growth factor (VEGF) receptor ... "This landmark proof-of-concept study will evaluate ...
(Date:9/2/2015)... , September 2, 2015 BiondVax ... of the National Institute of Allergy and Infectious Diseases (NIAID), ... the Department of Health and Human Services (HHS), to launch ... the United States in the 2015-16 timeframe. ... vaccine candidate, Multimeric-001 (M-001), as a primer vaccine, which would ...
(Date:9/2/2015)... ... September 02, 2015 , ... The ... creating professional commercial video content, to analysis of athletic performance. Producing high-resolution ... go by too quickly to process with the naked eye. , Slow ...
Breaking Biology Technology:Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3
Cached News: